|
Veno-occlusive disease in patients with B-ALL treated with inotuzumab ozogamicin followed by allogeneic stem cell transplantation & Immunotherapy in advanced non-small cell lung cancer: how long do we treat? |
08/05/2021 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference: Breast Cancer Outcomes by age and reace |
09/09/2021 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
09/30/2021 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
10/14/2021 - 12:00pm to 1:00pm |
|
Section M & M |
10/28/2021 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
11/11/2021 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
03/24/2022 - 12:00pm to 1:00pm |
|
M&M Conference |
03/31/2022 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
04/28/2022 - 12:00pm to 1:00pm |
|
Hematology/Oncology Fellows Conference |
05/26/2022 - 12:00pm to 1:00pm |
Facebook
Twitter
LinkedIn
Forward